DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MediPoint: Viscosupplementation - Global Analysis and Market Forecasts" report to their offering.
Global viscosupplementation market was estimated at $2.1B in 2016 spanning 39 markets. By the end of the forecast period in 2023, it is estimated that the market will grow to approximately $3.1B at a Compound Annual Growth Rate (CAGR) of 6.0%.
South America viscosupplementation market is projected to grow at a CAGR of 6.7% during the forecast period, followed by North America, APAC, Middle East and Africa at a CAGR of 6.4%, 6.3% and 5.0% respectively. The European viscosupplementation market is projected to grow at a CAGR of 3.5% during the forecast period. The US represented the largest portion of the market in 2016, holding 95.7% of the regional revenue, and is expected to maintain this dominance through the forecast period.
The market for viscosupplementation is highly fragmented, with key players varying by region and country. Unlike most orthopedic device markets, the market for viscosupplementation is largely populated by pharmaceutical companies. Although many companies maintain a direct presence in the markets they sell to, some have coordinated marketing and distribution partnerships with major orthopedic players in an effort to leverage geographical experience and existing relationships with orthopedic surgeons.
Key drivers of the viscosupplementation market are:
- The rising prevalence of osteoarthritis (OA) due to increasing aging and obese populations.
- The evolving multimodal treatment paradigm for OA.
- Patients seeking to delay knee replacement surgery in an effort to maintain an active lifestyle.
Companies mentioned in this report:
- Anika Therapeutics
- Ferring Pharmaceuticals
- Fidia Farmaceutici
- Seikagaku Corporation
Key Topics Covered:
1 About the Authors
2 Table of Contents
3 Executive Summary
5 Market Outlook
6 Market Insights
7 Competitive Assessment
For more information about this report visit https://www.researchandmarkets.com/research/slc7wq/medipoint